Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hosch, SB; Braun, S; Pantel, K
   Characterization of disseminated tumor cells
   SEMINARS IN SURGICAL ONCOLOGY
   
   S.B. Hosch et al., "Characterization of disseminated tumor cells", SEM SURG ON, 20(4), 2001, pp. 265-271
2. Pantel, K; Otte, M
   Occult micrometastasis: enrichment, identification and characterization ofsingle disseminated tumour cells
   SEMINARS IN CANCER BIOLOGY
   
   K. Pantel e M. Otte, "Occult micrometastasis: enrichment, identification and characterization ofsingle disseminated tumour cells", SEM CANC B, 11(5), 2001, pp. 327-337
3. Braun, S; Schindlbeck, C; Hepp, F; Janni, W; Kentenich, C; Reithmuller, G; Pantel, K
   Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Braun et al., "Occult tumor cells in bone marrow of patients with locoregionally restricted ovarian cancer predict early distant metastatic relapse", J CL ONCOL, 19(2), 2001, pp. 368-375
4. Braun, S; Harbeck, N; Pantel, K
   Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? - Reply
   JOURNAL OF CLINICAL ONCOLOGY
   
   S. Braun et al., "Is immunohistochemical analysis an appropriate diagnostic technique for bone marrow micrometastases? - Reply", J CL ONCOL, 19(15), 2001, pp. 3590-3592
5. Maletz, K; Kufer, P; Mack, M; Raum, T; Pantel, K; Riethmuller, G; Gruber, R
   Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity
   INTERNATIONAL JOURNAL OF CANCER
   
   K. Maletz et al., "Bispecific single-chain antibodies as effective tools for eliminating epithelial cancer cells from human stem cell preparations by redirected cell cytotoxicity", INT J CANC, 93(3), 2001, pp. 409-416
6. Braun, S; Schlimok, G; Heumos, I; Schaller, G; Riethdorf, L; Riethmuller, C; Pantel, K
   erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients
   CANCER RESEARCH
   
   S. Braun et al., "erbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients", CANCER RES, 61(5), 2001, pp. 1890-1895
7. Otte, M; Zafrakas, M; Riethdorf, L; Pichlmeier, U; Loning, T; Janicke, F; Pantel, K
   MAGE-A gene expression pattern in primary breast cancer
   CANCER RESEARCH
   
   M. Otte et al., "MAGE-A gene expression pattern in primary breast cancer", CANCER RES, 61(18), 2001, pp. 6682-6687
8. Janni, W; Hepp, F; Rjosk, D; Kentenich, C; Strobl, B; Schindlbeck, C; Hantschmann, P; Sommer, H; Pantel, K; Braun, S
   The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence
   CANCER
   
   W. Janni et al., "The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence", CANCER, 92(1), 2001, pp. 46-53
9. Zippelius, A; Lutterbuse, R; Riethmuller, G; Pantel, K
   Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells
   CLINICAL CANCER RESEARCH
   
   A. Zippelius et al., "Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells", CLIN CANC R, 6(7), 2000, pp. 2741-2750
10. Passlick, B; Sienel, W; Seen-Hibler, R; Wockel, W; Thetter, O; Mutschler, W; Pantel, K
    Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer
    CLINICAL CANCER RESEARCH
    
    B. Passlick et al., "Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer", CLIN CANC R, 6(10), 2000, pp. 3944-3948
11. Pantel, K; Doeberitz, MV
    Detection and clinical relevance of micrometastatic cancer cells
    CURRENT OPINION IN ONCOLOGY
    
    K. Pantel e M.V. Doeberitz, "Detection and clinical relevance of micrometastatic cancer cells", CURR OPIN O, 12(1), 2000, pp. 95-101
12. Braun, S; Kentenich, C; Janni, W; Hepp, F; de Waal, J; Willgeroth, F; Sommer, H; Pantel, K
    Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients
    JOURNAL OF CLINICAL ONCOLOGY
    
    S. Braun et al., "Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients", J CL ONCOL, 18(1), 2000, pp. 80-86
13. Pantel, K; Otte, M
    Identification and characterisation of minimal residual disease in solid tumors
    ACTA MEDICA AUSTRIACA
    
    K. Pantel e M. Otte, "Identification and characterisation of minimal residual disease in solid tumors", ACT MED AUS, 27, 2000, pp. 8-12
14. Braun, S; Schlimok, G; Pantel, K
    Bone marrow metastases in breast cancer - Reply
    NEW ENGLAND JOURNAL OF MEDICINE
    
    S. Braun et al., "Bone marrow metastases in breast cancer - Reply", N ENG J MED, 343(8), 2000, pp. 578-578
15. Braun, S; Pantel, K; Muller, P; Janni, W; Hepp, F; Kentenich, CRM; Gastroph, S; Wischnik, A; Dimpfl, T; Kindermann, G; Riethmuller, G; Schlimok, G
    Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    S. Braun et al., "Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.", N ENG J MED, 342(8), 2000, pp. 525-533
16. Passlick, B; Sienel, W; Seen-Hibler, R; Wockel, W; Thetter, O; Pantel, K
    The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells
    INTERNATIONAL JOURNAL OF CANCER
    
    B. Passlick et al., "The 17-1A antigen is expressed on primary, metastatic and disseminated non-small cell lung carcinoma cells", INT J CANC, 87(4), 2000, pp. 548-552
17. Hosch, S; Kraus, J; Scheunemann, P; Izbicki, JR; Schneider, C; Schumacher, U; Witter, K; Speicher, MR; Pantel, K
    Malignant potential and cytogenetic characteristics of occult disseminatedtumor cells in esophageal cancer
    CANCER RESEARCH
    
    S. Hosch et al., "Malignant potential and cytogenetic characteristics of occult disseminatedtumor cells in esophageal cancer", CANCER RES, 60(24), 2000, pp. 6836-6840
18. Gehling, UM; Ergun, S; Schumacher, U; Wagener, C; Pantel, K; Otte, M; Schuch, G; Schafhausen, P; Mende, T; Kilic, N; Kluge, K; Schafer, B; Hossfeld, DK; Fiedler, W
    In vitro differentiation of endothelial cells from AC133-positive progenitor cells
    BLOOD
    
    U.M. Gehling et al., "In vitro differentiation of endothelial cells from AC133-positive progenitor cells", BLOOD, 95(10), 2000, pp. 3106-3112
19. Braun, S; Pantel, K
    Diagnostic and clinical impact of disseminated tumour cells in bone marrow
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    S. Braun e K. Pantel, "Diagnostic and clinical impact of disseminated tumour cells in bone marrow", DEUT MED WO, 125(41), 2000, pp. 1237-1239
20. Borgen, E; Naume, B; Nesland, JM; Kvalheim, G; Beiske, K; Fodstad, O; Diel, I; Solomayer, EF; Theocharous, P; Coombes, RC; Smith, BM; Wunder, E; Marolleau, JP; Garcia, J; Pantel, K
    Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells
    CYTOTHERAPY
    
    E. Borgen et al., "Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells", CYTOTHERAPY, 1(5), 1999, pp. 377-388
21. Scheunemann, P; Hosch, SB; Witter, K; Kraus, J; Speicher, MR; Pantel, K; Izbicki, JR
    Biological relevance of occult tumor cells in a lymph node of a patient with resectable esophageal cancer
    LANGENBECKS ARCHIVES OF SURGERY
    
    P. Scheunemann et al., "Biological relevance of occult tumor cells in a lymph node of a patient with resectable esophageal cancer", LANG ARCH S, 1999, pp. 105-108
22. Hosch, SB; Stoecklein, N; Pichlmeier, U; Pantel, K; Izbicki, JR
    Plakoglobin downregulation as an indicator of an unfavourable prognosis inesophageal cancer
    LANGENBECKS ARCHIVES OF SURGERY
    
    S.B. Hosch et al., "Plakoglobin downregulation as an indicator of an unfavourable prognosis inesophageal cancer", LANG ARCH S, 1999, pp. 123-125
23. Braun, S; Pantel, K
    Micrometastatic bone marrow involvement: detection and prognostic significance
    MEDICAL ONCOLOGY
    
    S. Braun e K. Pantel, "Micrometastatic bone marrow involvement: detection and prognostic significance", MED ONCOL, 16(3), 1999, pp. 154-165
24. Braun, S; Hepp, F; Kentenich, CRM; Janni, W; Pantel, K; Riethmuller, G; Willgeroth, F; Sommer, HL
    Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow
    CLINICAL CANCER RESEARCH
    
    S. Braun et al., "Monoclonal antibody therapy with Edrecolomab in breast cancer patients: Monitoring of elimination of disseminated cytokeratin-positive tumor cells inbone marrow", CLIN CANC R, 5(12), 1999, pp. 3999-4004
25. Pantel, K; Witter, K
    Detection of disseminated epithelial tumor cells: Methods and clinical implications
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    K. Pantel e K. Witter, "Detection of disseminated epithelial tumor cells: Methods and clinical implications", INFUSIONSTH, 26(2), 1999, pp. 96-102
26. Kubuschok, B; Passlick, B; Izbicki, JR; Thetter, O; Pantel, K
    Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer
    JOURNAL OF CLINICAL ONCOLOGY
    
    B. Kubuschok et al., "Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer", J CL ONCOL, 17(1), 1999, pp. 19-24
27. Pantel, K
    Minimal residual cancer: Diagnostic approaches, prognostic relevance, biology and antibody therapy
    TUMORDIAGNOSTIK & THERAPIE
    
    K. Pantel, "Minimal residual cancer: Diagnostic approaches, prognostic relevance, biology and antibody therapy", TUMORDIAGN, 20(5), 1999, pp. 131-134
28. Roder, JD; Thorban, S; Pantel, K; Siewert, JR
    Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer
    WORLD JOURNAL OF SURGERY
    
    J.D. Roder et al., "Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer", WORLD J SUR, 23(9), 1999, pp. 888-891
29. Pantel, K
    Introductory overview
    CANCER AND METASTASIS REVIEWS
    
    K. Pantel, "Introductory overview", CANC METAST, 18(1), 1999, pp. 1-2
30. Braun, S; Pantel, K
    Biological characteristics of micrometastatic cancer cells in bone marrow
    CANCER AND METASTASIS REVIEWS
    
    S. Braun e K. Pantel, "Biological characteristics of micrometastatic cancer cells in bone marrow", CANC METAST, 18(1), 1999, pp. 75-90
31. Riethmuller, G; Klein, CA; Pantel, K
    Hunting down the seminal cells of clinical metastases
    IMMUNOLOGY TODAY
    
    G. Riethmuller et al., "Hunting down the seminal cells of clinical metastases", IMMUNOL TOD, 20(7), 1999, pp. 294-296
32. Scheunemann, P; Izbicki, JR; Pantel, K
    Tumorigenic potential of apparently tumor-free lymph nodes
    NEW ENGLAND JOURNAL OF MEDICINE
    
    P. Scheunemann et al., "Tumorigenic potential of apparently tumor-free lymph nodes", N ENG J MED, 340(21), 1999, pp. 1687-1687
33. Klein, CA; Schmidt-Kittler, O; Schardt, JA; Pantel, K; Speicher, MR; Riethmuller, G
    Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    C.A. Klein et al., "Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells", P NAS US, 96(8), 1999, pp. 4494-4499
34. Offner, S; Schmaus, W; Witter, K; Baretton, GB; Schlimok, G; Passlick, B; Riethmuller, G; Pantel, K
    p53 gene mutations are not required for early dissemination of cancer cells
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    S. Offner et al., "p53 gene mutations are not required for early dissemination of cancer cells", P NAS US, 96(12), 1999, pp. 6942-6946
35. Ahr, A; Scharl, A; Muller, M; von Minckwitz, G; Gatje, R; Pantel, K; Kaufmann, M
    Cross-reactive staining of normal bone-marrow cells by monoclonal antibody2E11
    INTERNATIONAL JOURNAL OF CANCER
    
    A. Ahr et al., "Cross-reactive staining of normal bone-marrow cells by monoclonal antibody2E11", INT J CANC, 84(5), 1999, pp. 502-505
36. Kollermann, J; Heseding, B; Helpap, B; Kollermann, MW; Pantel, K
    Comparative immunocytochemical assessment of isolated carcinoma cells in lymph nodes and bone marrow of patients with clinically localized prostate cancer
    INTERNATIONAL JOURNAL OF CANCER
    
    J. Kollermann et al., "Comparative immunocytochemical assessment of isolated carcinoma cells in lymph nodes and bone marrow of patients with clinically localized prostate cancer", INT J CANC, 84(2), 1999, pp. 145-149
37. Braun, S; Hepp, F; Sommer, HL; Pantel, K
    Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease
    INTERNATIONAL JOURNAL OF CANCER
    
    S. Braun et al., "Tumor-antigen heterogeneity of disseminated breast cancer cells: Implications for immunotherapy of minimal residual disease", INT J CANC, 84(1), 1999, pp. 1-5
38. Putz, E; Witter, K; Offner, S; Stosiek, P; Zippelius, A; Johnson, J; Zahn, R; Riethmuller, C; Pantel, K
    Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases
    CANCER RESEARCH
    
    E. Putz et al., "Phenotypic characteristics of cell lines derived from disseminated cancer cells in bone marrow of patients with solid epithelial tumors: Establishment of working models for human micrometastases", CANCER RES, 59(1), 1999, pp. 241-248
39. Passlick, B; Kubuschok, B; Izbicki, JR; Thetter, O; Pantel, K
    Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer
    ANNALS OF THORACIC SURGERY
    
    B. Passlick et al., "Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer", ANN THORAC, 68(6), 1999, pp. 2053-2058
40. Pantel, K; Cote, RJ; Fodstad, O
    Detection and clinical importance of micrometastatic disease
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    K. Pantel et al., "Detection and clinical importance of micrometastatic disease", J NAT CANC, 91(13), 1999, pp. 1113-1124
41. PASSLICK B; SEENHILBER R; WOCKEL W; HAUSSINGER K; THETTER O; PANTEL K
    THE 17-1A ANTIGEN IS EXPRESSED ON PRIMARY, METASTATIC AND DISSEMINATED NONSMALL CELL LUNG-CARCINOMA CELLS
    Annals of oncology
    
    B. Passlick et al., "THE 17-1A ANTIGEN IS EXPRESSED ON PRIMARY, METASTATIC AND DISSEMINATED NONSMALL CELL LUNG-CARCINOMA CELLS", Annals of oncology, 9, 1998, pp. 429-429
42. BRAUN S; HEPP F; JANNI W; SOMMER HL; PANTEL K
    REDUCTION OF MICROMETASTATIC TUMOR LOAD BY MONOCLONAL-ANTIBODY THERAPY - INFLUENCE OF TUMOR-ANTIGEN HETEROGENEITY
    Annals of oncology
    
    S. Braun et al., "REDUCTION OF MICROMETASTATIC TUMOR LOAD BY MONOCLONAL-ANTIBODY THERAPY - INFLUENCE OF TUMOR-ANTIGEN HETEROGENEITY", Annals of oncology, 9, 1998, pp. 619-619
43. PANTEL K; PASSLICK B; VOGT J; STOSIEK P; ANGSTWURM M; SEENHIBLER R; HAUSSINGER K; THETTER O; IZBICKI JR; RIETHMULLER G
    REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER
    Journal of clinical oncology
    
    K. Pantel et al., "REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN SUBSETS OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 16(4), 1998, pp. 1407-1413
44. ZIPPELIUS A; RIETHMULLER G; PANTEL K
    REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS - REPLY
    Journal of clinical oncology
    
    A. Zippelius et al., "REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION AND ISLET-CELL CARCINOMA - NOT ANTAGONIST, BUT COMPLEMENTARY TOOLS - REPLY", Journal of clinical oncology, 16(2), 1998, pp. 806-807
45. Braun, S; Pantel, K
    Prognostic significance of micrometastatic bone marrow involvement
    BREAST CANCER RESEARCH AND TREATMENT
    
    S. Braun e K. Pantel, "Prognostic significance of micrometastatic bone marrow involvement", BREAST CANC, 52(1-3), 1998, pp. 201-216
46. PANTEL K; AHR A
    IMMUNOCYTOCHEMICAL AND MOLECULAR STRATEGIES FOR THE DETECTION OF MICROMETASTASES IN PATIENTS WITH SOLID EPITHELIAL TUMORS - A REVIEW
    Nuclear medicine communications
    
    K. Pantel e A. Ahr, "IMMUNOCYTOCHEMICAL AND MOLECULAR STRATEGIES FOR THE DETECTION OF MICROMETASTASES IN PATIENTS WITH SOLID EPITHELIAL TUMORS - A REVIEW", Nuclear medicine communications, 19(6), 1998, pp. 521-527
47. HOSCH SB; PANTEL K; IZBICKI JR
    CRYPTIC TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH ESOPHAGEAL CANCER- REPLY
    The New England journal of medicine
    
    S.B. Hosch et al., "CRYPTIC TUMOR-CELLS IN LYMPH-NODES OF PATIENTS WITH ESOPHAGEAL CANCER- REPLY", The New England journal of medicine, 338(8), 1998, pp. 550-550
48. BORELLI S; SCHADENDORF D; RIETHMULLER G; PANTEL K
    IMMUNOHISTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF MELANOMA PATIENTS
    Journal of investigative dermatology
    
    S. Borelli et al., "IMMUNOHISTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF MELANOMA PATIENTS", Journal of investigative dermatology, 110(4), 1998, pp. 719-719
49. HOSCH SB; INNDORF S; BULL S; STERN F; PANTEL K; IZBICKI JR
    IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS 3D55 AND CD59 IN ESOPHAGEAL CANCER
    Gastroenterology
    
    S.B. Hosch et al., "IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS 3D55 AND CD59 IN ESOPHAGEAL CANCER", Gastroenterology, 114(4), 1998, pp. 93-93
50. HOSCH SB; STOECKLEIN NH; IZBICKI JR; PICHLMEIER U; PANTEL K
    REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN PATIENTS WITH ESOPHAGEAL CANCER
    Gastroenterology
    
    S.B. Hosch et al., "REDUCED EXPRESSION OF PLAKOGLOBIN INDICATES AN UNFAVORABLE PROGNOSIS IN PATIENTS WITH ESOPHAGEAL CANCER", Gastroenterology, 114(4), 1998, pp. 2519-2519
51. INNDORF S; HOSCH SB; LUETH M; SCHEUNEMANN P; PANTEL K; KNOEFEL WT; IZBICKI JR
    IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS CD55 AND CD59 IN LIVER METASTASES OF COLON-CANCER
    Gastroenterology
    
    S. Inndorf et al., "IMMUNOHISTOCHEMICAL ASSESSMENT OF 17-1A AND COMPLEMENT RESISTANCE FACTORS CD55 AND CD59 IN LIVER METASTASES OF COLON-CANCER", Gastroenterology, 114(4), 1998, pp. 2528-2528
52. SCHEUNEMANN P; HOSCH SB; WITTER K; PUTZ E; ZAHN R; SCHNEIDER C; PANTEL K; REEDERS A; IZBICKI JR
    ESTABLISHMENT AND COMPARATIVE CHARACTERIZATION OF 2 NEW HUMAN ESOPHAGEAL-CARCINOMA CELL-LINES DERIVED FROM LYMPH-NODE MICROMETASTATIC CELLSAND AUTOLOGOUS PRIMARY TUMOR
    Gastroenterology
    
    P. Scheunemann et al., "ESTABLISHMENT AND COMPARATIVE CHARACTERIZATION OF 2 NEW HUMAN ESOPHAGEAL-CARCINOMA CELL-LINES DERIVED FROM LYMPH-NODE MICROMETASTATIC CELLSAND AUTOLOGOUS PRIMARY TUMOR", Gastroenterology, 114(4), 1998, pp. 2778-2778
53. GATH HJ; HEISSLER E; HELL B; JEHLE M; PANTEL K; BIER J
    MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS IN THE HEAD AND NECK REGION
    British Journal of Cancer
    
    H.J. Gath et al., "MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS IN THE HEAD AND NECK REGION", British Journal of Cancer, 77, 1998, pp. 15-15
54. IZBICKI JR; PASSLICK B; PANTEL K; PICHLMEIER U; HOSCH SB; KARG O; THETTER O
    EFFECTIVENESS OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY IN PATIENTS WITH RESECTABLE NONSMALL CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    Annals of surgery
    
    J.R. Izbicki et al., "EFFECTIVENESS OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY IN PATIENTS WITH RESECTABLE NONSMALL CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL", Annals of surgery, 227(1), 1998, pp. 138-144
55. BRAUN S; MULLER M; HEPP F; SCHLIMOK G; RIETHMULLER G; PANTEL K
    MICROMETASTATIC BREAST-CANCER CELLS IN BONE-MARROW AT PRIMARY SURGERY- PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS
    Journal of the National Cancer Institute
    
    S. Braun et al., "MICROMETASTATIC BREAST-CANCER CELLS IN BONE-MARROW AT PRIMARY SURGERY- PROGNOSTIC VALUE IN COMPARISON WITH NODAL STATUS", Journal of the National Cancer Institute, 90(14), 1998, pp. 1099-1100
56. PASSLICK B; PANTEL K; IZBICKI JR; THETTER O
    DETECTION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITHRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - LONG-TERM RESULTS AFTER 5 YEARS OF FOLLOW-UP
    European journal of cancer
    
    B. Passlick et al., "DETECTION OF DISSEMINATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITHRESECTABLE NONSMALL CELL LUNG-CANCER (NSCLC) - LONG-TERM RESULTS AFTER 5 YEARS OF FOLLOW-UP", European journal of cancer, 33, 1997, pp. 1029-1029
57. ZIPPELIUS A; KUFER P; HONOLD G; KOLLERMANN MW; OBERNEDER R; SCHLIMOK G; RIETHMULLER G; PANTEL K
    LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW
    Journal of clinical oncology
    
    A. Zippelius et al., "LIMITATIONS OF REVERSE-TRANSCRIPTASE POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW", Journal of clinical oncology, 15(7), 1997, pp. 2701-2708
58. IZBICKI JR; HOSCH SB; PICHLMEIER U; REHDERS A; BUSCH C; NIENDORF A; PASSLICK B; BROELSCH CE; PANTEL K
    PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICALLY IDENTIFIABLE TUMOR-CELLS INLYMPH-NODES OF PATIENTS WITH COMPLETELY RESECTED ESOPHAGEAL CANCER
    The New England journal of medicine
    
    J.R. Izbicki et al., "PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICALLY IDENTIFIABLE TUMOR-CELLS INLYMPH-NODES OF PATIENTS WITH COMPLETELY RESECTED ESOPHAGEAL CANCER", The New England journal of medicine, 337(17), 1997, pp. 1188-1194
59. HOSCH SB; IZBICKI JR; PICHLMEIER U; STOECKLEIN N; NIENDORF A; KNOEFEL WT; BROELSCH CE; PANTEL K
    EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOREGULATORY MOLECULES IN ESOPHAGEAL CANCER
    International journal of cancer
    
    S.B. Hosch et al., "EXPRESSION AND PROGNOSTIC-SIGNIFICANCE OF IMMUNOREGULATORY MOLECULES IN ESOPHAGEAL CANCER", International journal of cancer, 74(6), 1997, pp. 582-587
60. PANTEL K; ENZMANN T; KOLLERMANN J; CAPRANO J; RIETHMULLER C; KOLLERMANN MW
    IMMUNOCYTOCHEMICAL MONITORING OF MICROMETASTATIC DISEASE - REDUCTION OF PROSTATE-CANCER CELLS IN BONE-MARROW BY ANDROGEN DEPRIVATION
    International journal of cancer
    
    K. Pantel et al., "IMMUNOCYTOCHEMICAL MONITORING OF MICROMETASTATIC DISEASE - REDUCTION OF PROSTATE-CANCER CELLS IN BONE-MARROW BY ANDROGEN DEPRIVATION", International journal of cancer, 71(4), 1997, pp. 521-525
61. HOCHTLENVOLLMAR W; GRUBER R; BODENMULLER H; LINDEMANN F; PASSLICK B; SCHLIMOK G; PANTEL K; RIETHMULLER G
    OCCULT EPITHELIAL TUMOR-CELLS DETECTED IN BONE-MARROW BY AN ENZYME-IMMUNOASSAY SPECIFIC FOR CYTOKERATIN-19
    International journal of cancer
    
    W. Hochtlenvollmar et al., "OCCULT EPITHELIAL TUMOR-CELLS DETECTED IN BONE-MARROW BY AN ENZYME-IMMUNOASSAY SPECIFIC FOR CYTOKERATIN-19", International journal of cancer, 70(4), 1997, pp. 396-400
62. PANTEL K; DOEBERITZ MV; IZBICKI JR; RIETHMULLER G
    DISSEMINATED TUMOR-CELLS - DIAGNOSIS, PROGNOSTIC VALUE, PHENOTYPING AND THERAPEUTIC STRATEGY
    Chirurg
    
    K. Pantel et al., "DISSEMINATED TUMOR-CELLS - DIAGNOSIS, PROGNOSTIC VALUE, PHENOTYPING AND THERAPEUTIC STRATEGY", Chirurg, 68(12), 1997, pp. 1241-1250
63. BRAUN S; HEPP F; SOMMER HL; RIETHMULLER G; PANTEL K
    HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY
    Blood
    
    S. Braun et al., "HETEROGENEOUS EXPRESSION OF TUMOR-ANTIGENS ON MICROMETASTATIC BREAST-CANCER CELLS - IMPLICATIONS FOR GENETIC APPROACHES OF CANCER-IMMUNOTHERAPY", Blood, 90(10), 1997, pp. 4591-4591
64. BRAUN S; MULLER M; HEPP F; JANNI W; KINDERMANN G; RIETHMULLER G; PANTEL K
    OCCULT HEMATOGENOUS DISSEMINATION OF CARCINOMA-CELLS IN PATIENTS WITHOVARIAN-CANCER
    Blood
    
    S. Braun et al., "OCCULT HEMATOGENOUS DISSEMINATION OF CARCINOMA-CELLS IN PATIENTS WITHOVARIAN-CANCER", Blood, 90(10), 1997, pp. 961-961
65. PANTEL K; PUTZ E; RIETHMULLER G
    IDENTIFICATION OF NEW THERAPEUTIC TARGETS ON BONE-MARROW MICROMETASTASES
    Blood
    
    K. Pantel et al., "IDENTIFICATION OF NEW THERAPEUTIC TARGETS ON BONE-MARROW MICROMETASTASES", Blood, 90(10), 1997, pp. 1871-1871
66. SCHALLER G; FUCHS I; PRITZE W; EBERT A; HERBST H; PANTEL K; WEITZEL H; LENGYEL E
    ELEVATED KERATIN-18 PROTEIN EXPRESSION INDICATES A FAVORABLE PROGNOSIS IN PATIENTS WITH BREAST-CANCER
    Clinical cancer research
    
    G. Schaller et al., "ELEVATED KERATIN-18 PROTEIN EXPRESSION INDICATES A FAVORABLE PROGNOSIS IN PATIENTS WITH BREAST-CANCER", Clinical cancer research, 2(11), 1996, pp. 1879-1885
67. THORBAN S; RODER JD; PANTEL K; SIEWERT JR
    EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA DETECTED BY IMMUNOCYTOCHEMICAL STAINING
    European journal of cancer
    
    S. Thorban et al., "EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA DETECTED BY IMMUNOCYTOCHEMICAL STAINING", European journal of cancer, 32A(2), 1996, pp. 363-365
68. PASSLICK B; PANTEL K; KUBUSCHOK B; ANGSTWURM M; NEHER A; THETTER O; SCHWEIBERER L; IZBICKI JR
    EXPRESSION OF MHC MOLECULES AND ICAM-1 ON NON-SMALL-CELL LUNG CARCINOMAS - ASSOCIATION WITH EARLY LYMPHATIC SPREAD OF TUMOR-CELLS
    European journal of cancer
    
    B. Passlick et al., "EXPRESSION OF MHC MOLECULES AND ICAM-1 ON NON-SMALL-CELL LUNG CARCINOMAS - ASSOCIATION WITH EARLY LYMPHATIC SPREAD OF TUMOR-CELLS", European journal of cancer, 32A(1), 1996, pp. 141-145
69. PANTEL K; RIETHMULLER G
    METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES
    Onkologie
    
    K. Pantel e G. Riethmuller, "METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES", Onkologie, 19(2), 1996, pp. 181-182
70. THORBAN S; RODER JD; NEKARDA H; FUNK A; PANTEL K; SIEWERT JR
    DISSEMINATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH ESOPHAGEAL CANCER - DETECTION AND PROGNOSTIC-SIGNIFICANCE
    World journal of surgery
    
    S. Thorban et al., "DISSEMINATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH ESOPHAGEAL CANCER - DETECTION AND PROGNOSTIC-SIGNIFICANCE", World journal of surgery, 20(5), 1996, pp. 567-573
71. PANTEL K; IZBICKI J; PASSLICK B; ANGSTWURM M; HAUSSINGER K; THETTER O; RIETHMULLER G
    FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER WITHOUT OVERT METASTASES
    Lancet
    
    K. Pantel et al., "FREQUENCY AND PROGNOSTIC-SIGNIFICANCE OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH NON-SMALL-CELL LUNG-CANCER WITHOUT OVERT METASTASES", Lancet, 347(9002), 1996, pp. 649-653
72. THORBAN S; RODER JD; PANTEL K; SIEWERT JR
    IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINA TED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA
    Zentralblatt fur Chirurgie
    
    S. Thorban et al., "IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINA TED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA", Zentralblatt fur Chirurgie, 121(6), 1996, pp. 487-489
73. PASSLICK B; PANTEL K
    PROGNOSTIC FACTORS IN STAGE-I NONSMALL CE LL LUNG-CANCER
    Zentralblatt fur Chirurgie
    
    B. Passlick e K. Pantel, "PROGNOSTIC FACTORS IN STAGE-I NONSMALL CE LL LUNG-CANCER", Zentralblatt fur Chirurgie, 121(10), 1996, pp. 851-857
74. PASSLICK B; THETTER O; PANTEL K; IZBICKI JR
    LIMITS OF SURGERY IN PATIENTS WITH APPARE NTLY LOCALIZED NONSMALL CELL LUNG-CANCER (PT1-3, PNO, MO)
    Langenbecks Archiv fur Chirurgie
    
    B. Passlick et al., "LIMITS OF SURGERY IN PATIENTS WITH APPARE NTLY LOCALIZED NONSMALL CELL LUNG-CANCER (PT1-3, PNO, MO)", Langenbecks Archiv fur Chirurgie, 1996, pp. 779-784
75. PASSLICK B; PANTEL K; STOSIEK P; HOSCH S; THETTER O; IZBICKI JR
    EXPRESSION OF PLAKOGLOBIN IN LUNG-CANCER - FREQUENCY AND PROGNOSTIC-SIGNIFICANCE
    Langenbecks Archiv fur Chirurgie
    
    B. Passlick et al., "EXPRESSION OF PLAKOGLOBIN IN LUNG-CANCER - FREQUENCY AND PROGNOSTIC-SIGNIFICANCE", Langenbecks Archiv fur Chirurgie, 1996, pp. 810-813
76. IZBICKI JR; PASSLICK B; HOSCH SB; KUBUSCHOCK B; SCHNEIDER C; BUSCH C; KNOEFEL WT; THETTER O; PANTEL K
    MODE OF SPREAD IN THE EARLY PHASE OF LYMPHATIC METASTASIS IN NON-SMALL-CELL LUNG-CANCER - SIGNIFICANCE OF NODAL MICROMETASTASIS
    Journal of thoracic and cardiovascular surgery
    
    J.R. Izbicki et al., "MODE OF SPREAD IN THE EARLY PHASE OF LYMPHATIC METASTASIS IN NON-SMALL-CELL LUNG-CANCER - SIGNIFICANCE OF NODAL MICROMETASTASIS", Journal of thoracic and cardiovascular surgery, 112(3), 1996, pp. 623-630
77. HOSCH SB; REHDERS A; PASSLICK B; SCHNEIDER C; PANTEL K; IZBICKI JR
    MINIMAL TUMOR-CELL DISSEMINATION IN ESOPHAGEAL CANCER - A CONTRADICTION TO LOCAL TREATMENT
    Gastroenterology
    
    S.B. Hosch et al., "MINIMAL TUMOR-CELL DISSEMINATION IN ESOPHAGEAL CANCER - A CONTRADICTION TO LOCAL TREATMENT", Gastroenterology, 110(4), 1996, pp. 531-531
78. ORUZIO D; PANTEL K; HEMPEL D; LINDEMANN F; WITTE J; PERSSON B; RIETHMULLER G; SCHLIMOK G
    EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER
    Blood
    
    D. Oruzio et al., "EXPRESSION OF AN ANTIGEN RECOGNIZED BY C-242 MONOCLONAL, ANTIBODY ON MINIMAL RESIDUAL TUMOR-CELLS IN BONE-MARROW FROM PATIENTS WITH COLORECTAL-CANCER", Blood, 88(10), 1996, pp. 3326-3326
79. PANTEL K; BRAUN S; SCHLIMOK G; RIETHMULLER G
    BIOLOGICAL HETEROGENEITY OF MICROMETASTATIC BREAST-CANCER CELLS - CLINICAL IMPLICATIONS
    Blood
    
    K. Pantel et al., "BIOLOGICAL HETEROGENEITY OF MICROMETASTATIC BREAST-CANCER CELLS - CLINICAL IMPLICATIONS", Blood, 88(10), 1996, pp. 1921-1921
80. ZIPPELIUS A; KUFER P; HONOLD G; RIETHMULLER G; PANTEL K
    LIMITATIONS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW
    Blood
    
    A. Zippelius et al., "LIMITATIONS OF REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION ANALYSES FOR DETECTION OF MICROMETASTATIC EPITHELIAL CANCER-CELLS IN BONE-MARROW", Blood, 88(10), 1996, pp. 2431-2431
81. PASSLICK B; IZBICKI JR; KUBUSCHOK B; THETTER O; PANTEL K
    DETECTION OF DISSEMINATED LUNG-CANCER CELLS IN LYMPH-NODES - IMPACT ON STAGING AND PROGNOSIS
    The Annals of thoracic surgery
    
    B. Passlick et al., "DETECTION OF DISSEMINATED LUNG-CANCER CELLS IN LYMPH-NODES - IMPACT ON STAGING AND PROGNOSIS", The Annals of thoracic surgery, 61(1), 1996, pp. 177-182
82. THORBAN S; RODER JD; PANTEL K; SIEWERT R
    IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA
    The American journal of surgery
    
    S. Thorban et al., "IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED EPITHELIAL TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH PANCREATIC-CARCINOMA", The American journal of surgery, 172(3), 1996, pp. 297-298
83. TERPE HJ; STORKEL S; ZIMMER U; ANQUEZ V; FISCHER C; PANTEL K; GUNTHERT U
    EXPRESSION OF CD44 ISOFORMS IN RENAL-CELL TUMORS - POSITIVE CORRELATION TO TUMOR DIFFERENTIATION
    The American journal of pathology
    
    H.J. Terpe et al., "EXPRESSION OF CD44 ISOFORMS IN RENAL-CELL TUMORS - POSITIVE CORRELATION TO TUMOR DIFFERENTIATION", The American journal of pathology, 148(2), 1996, pp. 453-463
84. THORBAN S; RODER JD; NEKARDA H; FUNK A; SIEWERT JR; PANTEL K
    IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINATED TUMOR-CELLS IN THE BONE-MARROW OF PATIENTS WITH ESOPHAGEAL-CARCINOMA
    Journal of the National Cancer Institute
    
    S. Thorban et al., "IMMUNOCYTOCHEMICAL DETECTION OF DISSEMINATED TUMOR-CELLS IN THE BONE-MARROW OF PATIENTS WITH ESOPHAGEAL-CARCINOMA", Journal of the National Cancer Institute, 88(17), 1996, pp. 1222-1227
85. SCHLIMOK G; PANTEL K; LOIBNER H; FACKLERSCHWALBE I; RIETHMULLER G
    REDUCTION OF METASTATIC CARCINOMA-CELLS IN BONE-MARROW BY INTRAVENOUSLY ADMINISTERED MONOCLONAL-ANTIBODY - TOWARDS A NOVEL SURROGATE TEST TO MONITOR ADJUVANT THERAPIES OF SOLID TUMORS
    European journal of cancer
    
    G. Schlimok et al., "REDUCTION OF METASTATIC CARCINOMA-CELLS IN BONE-MARROW BY INTRAVENOUSLY ADMINISTERED MONOCLONAL-ANTIBODY - TOWARDS A NOVEL SURROGATE TEST TO MONITOR ADJUVANT THERAPIES OF SOLID TUMORS", European journal of cancer, 31A(11), 1995, pp. 1799-1803
86. PANTEL K; AIGNHERR C; KOLLERMANN J; CAPRANO J; RIETHMULLER G; KOLLERMANN MW
    IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH UNTREATED STAGE-C PROSTATIC-CANCER
    European journal of cancer
    
    K. Pantel et al., "IMMUNOCYTOCHEMICAL DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH UNTREATED STAGE-C PROSTATIC-CANCER", European journal of cancer, 31A(10), 1995, pp. 1627-1632
87. PANTEL K; RIETHMULLER G
    IMMUNOTHERAPEUTIC APPROACHES DIRECTED AGAINST MINIMAL RESIDUAL CANCER
    European journal of cancer
    
    K. Pantel e G. Riethmuller, "IMMUNOTHERAPEUTIC APPROACHES DIRECTED AGAINST MINIMAL RESIDUAL CANCER", European journal of cancer, 31A, 1995, pp. 87-87
88. GATH HJ; HEISSLER E; HELL B; BIER J; RIETHMULLER G; PANTEL K
    IMMUNOCYTOLOGIC DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION
    International journal of oral and maxillofacial surgery
    
    H.J. Gath et al., "IMMUNOCYTOLOGIC DETECTION OF ISOLATED TUMOR-CELLS IN BONE-MARROW OF PATIENTS WITH SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION", International journal of oral and maxillofacial surgery, 24(5), 1995, pp. 351-355
89. BRAUN S; PANTEL K
    IMMUNOLOGICAL APPROACHES TO DETECT AND CHARACTERIZE INDIVIDUAL MICRODISSEMINATED COLON-CANCER CELLS
    Journal of experimental & clinical cancer research
    
    S. Braun e K. Pantel, "IMMUNOLOGICAL APPROACHES TO DETECT AND CHARACTERIZE INDIVIDUAL MICRODISSEMINATED COLON-CANCER CELLS", Journal of experimental & clinical cancer research, 14(2), 1995, pp. 29-35
90. PANTEL K; RIETHMULLER G
    METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES
    Onkologie
    
    K. Pantel e G. Riethmuller, "METHODS FOR DETECTION OF MICROMETASTATIC CARCINOMA-CELLS IN BONE-MARROW, BLOOD AND LYMPH-NODES", Onkologie, 18(5), 1995, pp. 394-401
91. ZIPPELIUS A; HONOLD G; KUFER P; SCHLIMOK G; RIETHMULLER G; PANTEL K
    POTENTIAL AND LIMITATIONS OF RT-PCR FOR DETECTION OF ISOLATED CARCINOMA-CELLS IN BONE-MARROW
    Experimental hematology
    
    A. Zippelius et al., "POTENTIAL AND LIMITATIONS OF RT-PCR FOR DETECTION OF ISOLATED CARCINOMA-CELLS IN BONE-MARROW", Experimental hematology, 23(8), 1995, pp. 763-763
92. BRAUN S; HEPP F; MAASSEN V; KINDERMANN G; RIETHMULLER G; PANTEL K
    DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITHBREAST, CERVICAL, AND OVARIAN-CANCER
    Experimental hematology
    
    S. Braun et al., "DETECTION OF MINIMAL RESIDUAL DISEASE IN BONE-MARROW OF PATIENTS WITHBREAST, CERVICAL, AND OVARIAN-CANCER", Experimental hematology, 23(8), 1995, pp. 763-763
93. BRAUN S; ANGSTWURM M; KUTTER D; VOGT J; SCHMAUS W; SCHLIMOK G; RIETHMULLER G; PANTEL K
    PHENOTYPE OF DISSEMINATED CARCINOMA-CELLS IN BONE-MARROW
    Experimental hematology
    
    S. Braun et al., "PHENOTYPE OF DISSEMINATED CARCINOMA-CELLS IN BONE-MARROW", Experimental hematology, 23(8), 1995, pp. 764-764
94. BRAUN S; PANTEL K
    IMMUNODIAGNOSIS AND IMMUNOTHERAPY OF ISOLATED TUMOR-CELLS DISSEMINATED TO BONE-MARROW OF PATIENTS WITH COLORECTAL-CANCER
    Tumori
    
    S. Braun e K. Pantel, "IMMUNODIAGNOSIS AND IMMUNOTHERAPY OF ISOLATED TUMOR-CELLS DISSEMINATED TO BONE-MARROW OF PATIENTS WITH COLORECTAL-CANCER", Tumori, 81(3), 1995, pp. 78-83
95. PANTEL K; GATH H
    STAGING OF HEAD AND NECK-CANCER
    The New England journal of medicine
    
    K. Pantel e H. Gath, "STAGING OF HEAD AND NECK-CANCER", The New England journal of medicine, 332(26), 1995, pp. 1788-1788
96. PASSLICK B; IZBICKI JR; HAUSSINGER K; THETTER O; PANTEL K
    IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IS NOT ASSOCIATED WITH APOOR-PROGNOSIS IN NON-SMALL-CELL LUNG-CANCER
    Journal of thoracic and cardiovascular surgery
    
    B. Passlick et al., "IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IS NOT ASSOCIATED WITH APOOR-PROGNOSIS IN NON-SMALL-CELL LUNG-CANCER", Journal of thoracic and cardiovascular surgery, 109(6), 1995, pp. 1205-1211
97. FLIEGER D; GRUBER R; SCHLIMOK G; REITER C; PANTEL K; RIETHMULLER G
    A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS
    Journal of immunological methods
    
    D. Flieger et al., "A NOVEL NONRADIOACTIVE CELLULAR CYTOTOXICITY TEST BASED ON THE DIFFERENTIAL-ASSESSMENT OF LIVING AND KILLED TARGET AND EFFECTOR-CELLS", Journal of immunological methods, 180(1), 1995, pp. 1-13
98. PASSLICK B; IZBICKI JR; REHDERS A; KNOEFEL WT; HOSCH SB; PANTEL K; BROELSCH CE
    LYMPH-NODE MICROMETASTASES IN PATIENTS WITH ESOPHAGEAL-CARCINOMA
    Gastroenterology
    
    B. Passlick et al., "LYMPH-NODE MICROMETASTASES IN PATIENTS WITH ESOPHAGEAL-CARCINOMA", Gastroenterology, 108(4), 1995, pp. 523-523
99. PASSLICK B; THETTER O; PANTEL K; KUBUSCHOK B; PICHLMEIER U; IZBICKI JR
    RELEVANCE OF REGIONAL LYMPHATIC TUMOR-CEL L DISSEMINATION IN PATIENTSWITH RESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE-STUDY
    Chirurg
    
    B. Passlick et al., "RELEVANCE OF REGIONAL LYMPHATIC TUMOR-CEL L DISSEMINATION IN PATIENTSWITH RESECTABLE NON-SMALL-CELL LUNG-CANCER - RESULTS OF A PROSPECTIVE-STUDY", Chirurg, 66(8), 1995, pp. 780-785
100. IZBICKI JR; PASSLICK B; KARG O; BLOECHLE C; PANTEL K; KNOEFEL WT; THETTER O
     IMPACT OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY ON TUMOR STAGING IN LUNG-CANCER
     The Annals of thoracic surgery
     
     J.R. Izbicki et al., "IMPACT OF RADICAL SYSTEMATIC MEDIASTINAL LYMPHADENECTOMY ON TUMOR STAGING IN LUNG-CANCER", The Annals of thoracic surgery, 59(1), 1995, pp. 209-214